655 related articles for article (PubMed ID: 33436584)
1. Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.
Cao Y; Xie L; Shi F; Tang M; Li Y; Hu J; Zhao L; Zhao L; Yu X; Luo X; Liao W; Bode AM
Signal Transduct Target Ther; 2021 Jan; 6(1):15. PubMed ID: 33436584
[TBL] [Abstract][Full Text] [Related]
2. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.
Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K
Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515
[TBL] [Abstract][Full Text] [Related]
4. The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications.
Hu J; Li H; Luo X; Li Y; Bode A; Cao Y
Int J Cancer; 2017 Nov; 141(9):1722-1729. PubMed ID: 28571118
[TBL] [Abstract][Full Text] [Related]
5. Genetics of Epstein-Barr virus infection.
Hiraki A; Fujii N; Masuda K; Ikeda K; Tanimoto M
Biomed Pharmacother; 2001 Sep; 55(7):369-72. PubMed ID: 11669499
[TBL] [Abstract][Full Text] [Related]
6. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
Church TM; Verma D; Thompson J; Swaminathan S
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
Tatfi M; Hermine O; Suarez F
Front Immunol; 2018; 9():3060. PubMed ID: 30662441
[TBL] [Abstract][Full Text] [Related]
8. The danger molecule HMGB1 cooperates with the NLRP3 inflammasome to sustain expression of the EBV lytic switch protein in Burkitt lymphoma cells.
Reinhart NM; Akinyemi IA; Frey TR; Xu H; Agudelo C; Brathwaite J; Burton EM; Burgula S; McIntosh MT; Bhaduri-McIntosh S
Virology; 2022 Jan; 566():136-142. PubMed ID: 34922257
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr Virus and Systemic Autoimmune Diseases.
Houen G; Trier NH
Front Immunol; 2020; 11():587380. PubMed ID: 33488588
[TBL] [Abstract][Full Text] [Related]
10. DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA.
Wang'ondu R; Teal S; Park R; Heston L; Delecluse H; Miller G
PLoS One; 2015; 10(5):e0126088. PubMed ID: 25950714
[TBL] [Abstract][Full Text] [Related]
11. Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus.
Jog NR; James JA
Front Immunol; 2020; 11():623944. PubMed ID: 33613559
[TBL] [Abstract][Full Text] [Related]
12. [Epstein-Barr virus (
Yakushina SA; Kisteneva LB
Vopr Virusol; 2020 Sep; 65(4):191-202. PubMed ID: 33533222
[TBL] [Abstract][Full Text] [Related]
13. [Regulation and evasion of host immune responses by Epstein-Barr virus].
Xiao N; Chen Q; Cai S
Wei Sheng Wu Xue Bao; 2016 Jan; 56(1):19-25. PubMed ID: 27305776
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation.
Liu X; Sadaoka T; Krogmann T; Cohen JI
J Virol; 2020 May; 94(11):. PubMed ID: 32213613
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta.
Zhao M; Nanbo A; Becnel D; Qin Z; Morris GF; Li L; Lin Z
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847852
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
[TBL] [Abstract][Full Text] [Related]
17. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH
Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth.
Tobollik S; Meyer L; Buettner M; Klemmer S; Kempkes B; Kremmer E; Niedobitek G; Jungnickel B
Blood; 2006 Dec; 108(12):3859-64. PubMed ID: 16882707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
